Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Net Margin (2020 - 2025)

Pulse Biosciences (PLSE) has 4 years of Net Margin data on record, last reported at 6601.52% in Q4 2025.

  • For Q4 2025, Net Margin changed N/A year-over-year to 6601.52%; the TTM value through Dec 2025 reached 20779.71%, changed N/A, while the annual FY2025 figure was 20779.71%, N/A changed from the prior year.
  • Net Margin reached 6601.52% in Q4 2025 per PLSE's latest filing, up from 22486.05% in the prior quarter.
  • Across five years, Net Margin topped out at 102188.89% in Q4 2022 and bottomed at 22486.05% in Q3 2025.
  • Average Net Margin over 3 years is 8792.07%, with a median of 2488.15% recorded in 2021.
  • Peak YoY movement for Net Margin: soared 22734013bps in 2021, then plummeted -2034032bps in 2022.
  • A 3-year view of Net Margin shows it stood at 1826.54% in 2021, then surged by 5695bps to 102188.89% in 2022, then tumbled by -106bps to 6601.52% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 6601.52% in Q4 2025, 22486.05% in Q3 2025, and 102188.89% in Q4 2022.